Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 21 - 40 out of 500 displayed.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

AIT Therapeutics Announces $9.82 Million Private Placement

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

NEOVACS :2018 Financial Calendar

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

LifeLabs, a proud member of the Digital Technology Supercluster, winner of federal funding and poised to supercharge Canada’s economy and technology sector

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

Inovalon to Participate at The Morgan Stanley Technology, Media & Telecom Conference

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

Medifirst Solutions Announces a Business Update

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

Avinger Announces Closing of $18 Million Underwritten Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

HydRx Farms Ltd. (d/b/a Scientus Pharma Inc.) Announces Completion of its $15.8 Million Private Placement Offering of Common Shares

Read more ››
By: Nasdaq / GlobenewsWire - 16 Feb 2018

Great Point Partners, LLC Opposes The BioCryst Pharmaceutical Proposed Merger With Idera Pharmaceuticals, Inc.

GREENWICH, Conn., Feb. 16, 2018 /PRNewswire/ -- Great Point Partners, LLC ("GPP") today submitted a letter to the Board of Directors of BioCryst Pharmaceuticals, Inc. ("BCRX") expressing its opposition to BCRX's proposed merger with Idera Pharmaceuticals, Inc. The full text of the letter can... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  BioCryst Pharmaceuticals, Inc.

Hartford HealthCare Pioneers New Technology For Patients with Parkinson's Disease and Essential Tremor

HARTFORD, Conn., Feb. 16, 2018 /PRNewswire/ -- Hartford HealthCare's Ayer Neuroscience Institute has pioneered the most advanced Deep Brain Stimulation technology for patients with Parkinson's disease and essential tremor, becoming the first in Connecticut and among the first in New England to... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

Global Eye Glasses and Contact Lenses Market 2018-2023: Major Vendors Include Cooper Vision, Essilor International SA, Novartis AG, Luxottica Group and Johnson & Johnson

DUBLIN, Feb. 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

Multicenter meta-analysis reveals sepsis patients can be risk stratified at the time of diagnosis demonstrating potential to improve critical care medicine on a global scale

MOBILE, Ala., Feb. 16, 2018 /PRNewswire/ -- Why do some people die after they develop a severe infection while others with similar risk factors survive? Sepsis, which is defined by a life-threatening dysregulated host immune response to infection, is a leading cause of in-hospital deaths in the... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

Entyvio® (vedolizumab) Shows Higher Rates of Mucosal Healing Versus TNFa-Antagonist Therapy in Ulcerative Colitis and Crohn's Disease Patients in Comparative Effectiveness Real-World Data Analysis

OSAKA, Japan, February 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

AbbVie Announces New Phase 2 Data for Upadacitinib Showing Clinical and Endoscopic Outcomes in Crohn's Disease at 52 Weeks

NORTH CHICAGO, Ill., Feb. 16, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, today announced new results from the double-blinded extension phase of the Phase 2 CELEST study, showing that many patients treated with upadacitinib who... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  AbbVie Inc.

Abbott Declares 377th Consecutive Quarterly Dividend

ABBOTT PARK, Ill., Feb. 16, 2018 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 28 cents per share.

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  Abbott Laboratories

Global Acute Decompensated Heart Failure Forecast and Market Analysis to 2034: Recent Pipeline Discontinuations and Negative Trial Results Have Limited the Future Growth

DUBLIN, Feb. 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

Veterinary foundations announce recipients of pharmacology research grants

SCHAUMBURG, Ill., Feb. 16, 2018 /PRNewswire-USNewswire/ -- The American Veterinary Medical Foundation (AVMF) and the Veterinary Pharmacology Research Foundation (VPRF) have selected two veterinary researchers as recipients of the organizations' pharmacology research grants.

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018
Related companies:  American Veterinary Medical Association

New Report Provides Road Map for Pharmaceutical Industry on how to Ensure Medical Affairs Success in Emerging Regions of the World

CHAPEL HILL, N.C., Feb. 16, 2018 /PRNewswire/ -- As pharmaceutical companies seek out growth opportunities in new areas of the world, many are turning their attention to the TMEA region that includes Turkey, the Middle East and South Africa.

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

Global Stroke Prevention in Atrial Fibrillation Market 2017-2024: Survey of 213 Cardiologists in the US, Japan, and Five Major EU markets Sheds Light on Prescribing Trends in SPAF.

DUBLIN, Feb. 16, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2018

PCMA: CMS Report: PBM Tools Reduce Prescription Drug Costs

WASHINGTON, Feb. 16, 2018 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) released the following statement on new National Health Expenditure (NHE) data by the Centers for Medicare & Medicaid Services (CMS) on prescription drug costs, showing that... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018

Fayette Executive Health Offers GAINSWave in Fayetteville, Georgia

FAYETTEVILLE, Ga., Feb. 16, 2018 /PRNewswire/ -- Fayette Executive Health, is pleased to announce they now offer GAINSWave(TM)! This breakthrough noninvasive medical therapy uses low-intensity... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2018
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑